TECSYS Inc. Earnings Call Signals Profitable SaaS Growth

TECSYS Inc. ((TSE:TCS)) has held its Q3 earnings call. Read on for the main highlights of the call.

TECSYS Inc. struck an upbeat tone on its latest earnings call, emphasizing record SaaS bookings, a sharply higher adjusted EBITDA and a fast‑growing deal pipeline. Management acknowledged FX pressure, known noncore customer churn and a restructuring charge, but framed these as manageable headwinds against a backdrop of accelerating SaaS momentum and expanding margins.

Strong SaaS Revenue and ARR Growth

SaaS revenue rose 17% year over year to CA$20.1 million in Q3, or 18% on a constant‑currency basis, underscoring the shift toward recurring cloud income. Total SaaS ARR reached CA$83.3 million, up 10% reported and 16% in constant currency, with core Elite SaaS ARR advancing a robust 17% reported and 23% on a constant‑currency basis.

Record Adjusted EBITDA and Margin Expansion

Profitability advanced meaningfully, with adjusted EBITDA hitting a record CA$5.0 million in Q3, up 43% from a year ago and lifting gross margin to 51% from 47%. Net income improved to CA$1.7 million and EPS to CA$0.12, while year‑to‑date adjusted EBITDA climbed to CA$13.3 million, roughly 46% above the prior‑year period.

Record Q3 SaaS Bookings and Pipeline Strength

The company posted the largest Q3 SaaS bookings in its history, achieved even without migration‑related deals, signaling healthy underlying demand. New‑logo momentum was particularly strong, with bookings from fresh customers up more than 150% over the last 12 months and the overall pipeline ending Q3 about 30% higher year over year.

Revenue Growth and Fortress Balance Sheet

For the first nine months of fiscal 2026, SaaS revenue rose 21% to CA$58.9 million, helping push total revenue up 10% to CA$143.1 million, or 9% in constant currency. Excluding hardware, revenue expanded 13% and the company ended the quarter with CA$36.2 million in cash and short‑term investments and no debt, providing ample financial flexibility.

Healthcare and Pharmacy Market Traction

TECSYS highlighted growing traction in healthcare and pharmacy, adding marquee names such as Memorial Sloan Kettering and UT Southwestern to its customer roster. Management pointed to pharmacy pipeline growth of more than 200% year over year and sharply higher Pharmacy Summit registrations as evidence of rising brand recognition among health systems.

Commercial Launch of TecsysIQ and AI Upside

The commercial debut of TecsysIQ in Q3 gives customers an AI‑powered layer that blends external healthcare data with internal information to surface actionable supply chain insights. Management expects TecsysIQ to contribute a baseline of incremental ARR over time and to deepen customer stickiness, positioning AI as a meaningful growth accelerant rather than a distant bet.

Customer Attrition, FX and Services Backlog Headwinds

Management flagged that churn from a small set of noncore customers will trim roughly CA$1 million from ARR over the next couple of quarters, moderating headline ARR growth. Q3 SaaS ARR was also dampened by a CA$2.1 million FX headwind, while professional services backlog fell 19% year over year to CA$36 million after a tough comparison, signaling slower services demand.

Restructuring to Unlock Cost Savings

After quarter‑end, TECSYS initiated a workforce reduction of about 7%, which will result in an estimated CA$4.5 million restructuring charge in Q4. The company expects the move to generate approximately CA$8.1 million of annual operating cost savings, supporting further margin expansion as the SaaS business continues to scale.

AI Adoption Timeline and Customer Readiness

While management is optimistic about TecsysIQ, they cautioned that fully autonomous AI agents will take time to gain widespread acceptance among customers. Many organizations are still building trust in AI‑driven decisions, meaning broader automated actioning is likely to ramp over multiple quarters rather than contribute immediately in a material way.

Reaffirmed Outlook and Capital Deployment

Guidance was reaffirmed for fiscal 2026, with TECSYS still targeting SaaS revenue growth of 20% to 22%, total revenue growth of 8% to 10% and an adjusted EBITDA margin between 8% and 9%. Management expects Q4 professional services revenue to resemble Q3 levels, will absorb the restructuring charge while pursuing CA$8.1 million in annual savings, and highlighted its debt‑free balance sheet and ongoing dividend as support for shareholder returns.

TECSYS’s earnings call painted a picture of a SaaS‑driven growth story gaining traction, with record bookings, rising margins and deepening healthcare penetration offsetting manageable short‑term pressures. For investors, the reaffirmed guidance, strong cash position and emerging AI platform suggest the company is leaning into profitable growth while carefully navigating currency, churn and restructuring noise.